Finny logo
Finny logo
Dibs:
Dibs:
0

Portola Pharmaceuticals (PTLA) earnings: expect 214% revenue growth

5:05 pm ET, 07 May 2019

Portola Pharmaceuticals, Inc. (PTLA) is announcing earnings on May 08, before market opening. Wondering what revenue and earnings will look like?

What should you expect from the upcoming earnings?

Revenue for the next quarter is expected to be $21M, which implies 214% growth rate year-over-year.

Earnings per share are expected to come in at $-1.02. If this materializes, EPS will grow 20% year-over-year.

How did the stock do last month?

Over the last month, Portola Pharmaceuticals, Inc. (PTLA) returned +12.19%.

What do analysts say about the stock?

Portola Pharmaceuticals, Inc. (PTLA) average analyst price target is 17.28% above its current price ($35.30).

For the latest price and information on Portola Pharmaceuticals, Inc., please visit Finstead and ask for "PTLA", "PTLA analysis" or "PTLA news".

Portola Pharmaceuticals, Inc. (PTLA) Stock Guide

Updated at: 11:31 am ET, 18 Sep 2020

Before we start: if you're looking for PTLA stock price, you can quickly find it out by visiting Finny and typing "PTLA quote". If you're looking for a quick scoop on PTLA stock (chart, price target, market cap, news and buy or sell analysis), go to Finny and look for "PTLA". You'll get all this info in one place. Or you can just type "PTLA news" to get the latest stock news.

Looking to buy or sell Portola Pharmaceuticals, Inc. (PTLA)? Interested in getting the full scoop on PTLA, including earnings and dividends, stock forecast, buy or sell analysis and key stats? If so, you came to the right place.

In this PTLA stock guide, we'll address key questions about PTLA, above and beyond what you can find on Yahoo Finance, Zacks, MarketWatch or Morningstar.

Here is what you'll be able to find in this guide:

Analyst Predictions: stock forecast and analyst ratings;
Analysis: Finny Score and buy or sell analysis;
Key Stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio, industry, sector, and number of employees.

And here is the list of questions we'll answer:
1. What is PTLA stock forecast (i.e., prediction)?
2. PTLA buy or sell? What is PTLA Finny Score?
3. What are the reasons to buy PTLA? Why should I buy PTLA stock?
4. What are the reasons to sell PTLA? Why should I sell PTLA stock?
5. What are PTLA key stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

So let's start. Scroll down to the question that interests you the most.

Analyst Predictions

1. What is PTLA stock forecast (i.e., prediction)?

Based on PTLA analyst price targets, PTLA stock forecast is $19.57 (for a year from now). That means the average analyst price target for PTLA stock is $19.57. The prediction is based on 6 analyst estimates.

The low price target for PTLA is $9.00, while the high price target is $31.00.

PTLA analyst rating is Buy.

Analysis

2. PTLA buy or sell? What is PTLA Finny Score?

#{finnyScore:null}Our quantitative analysis shows 1 reason to buy and 2 reasons to sell PTLA. PTLA doesn’t have an assigned Finny Score, because we don’t have sufficient data points to score the stock.

3. What are the reasons to buy PTLA? Why should I buy PTLA stock?

Here are the reasons to buy PTLA stock:

4. What are the reasons to sell PTLA? Why should I sell PTLA stock?

Let's look at the reasons to sell PTLA stock (i.e., the bear case):

  • PTLA stock price ($18.03) is at the 52-week high. Perhaps now is a good time to sell? See PTLA price chart.
  • PTLA profitability is declining. The YoY profit margin change was -511.13 percentage points. See PTLA profitability chart.

Key Stats

5. What are PTLA key stats : revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

Let's look at the key statistics for PTLA:

Metrics PTLA
Price $18.00
Average Price Target / Upside $19.57 / 8.69%
Average Analyst Rating Buy
Forward Dividend Yield 0.00%
Industry Biotechnology
Sector Healthcare
Number of Employees 324
Market Cap $1.42B
Forward P/E Ratio -9.80
Price/Book Ratio N/A
Revenue (TTM) N/A
YoY Quarterly Revenue Growth N/A
Profit Margin N/A

If you liked this analysis, check out Stock Guides for other stocks.

Follow Us